Fine Foods & Pharmaceuticals Ntm Logo

Fine Foods & Pharmaceuticals Ntm

A CSDMO specializing in solid oral forms for the pharma and nutraceutical sectors.

FF | XMIL

Overview

Corporate Details

ISIN(s):
IT0005215329 (+1 more)
LEI:
8156009111DEE8553765
Country:
Italy
Address:
VIA BERLINO, 39 (ZINGONIA), 24040 VERDELLINO

Description

Fine Foods & Pharmaceuticals Ntm is an integrated Contract Sales and Development Manufacturing Organization (CSDMO) specializing in the development and contract manufacturing of products for third parties. The company's core expertise is in solid oral forms for the pharmaceutical and nutraceutical sectors. Its services also extend to the production of medical devices, cosmetics, and biocides. The organization applies a principle of scientific rigor across all its operations, emphasizing technological innovation, manufacturing excellence, and quality. With a significant portion of its workforce dedicated to science, the company acts as a strategic manufacturing partner to support client growth.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-05-09 09:30
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Italian 469.7 KB
2022-05-02 18:46
REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE - FINANCIAL YEAR 2021
English 780.5 KB
2022-05-02 13:04
Allegato 3F / Annex 3F
Italian 211.2 KB
2022-05-02 12:53
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Latin 811.5 KB
2022-04-26 15:20
REPORT ON REMUNERATION POLICY AND COMPENSATION
English 565.3 KB
2022-04-26 09:56
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Latin 612.6 KB
2022-04-21 10:29
Annual Financial Report as of 31 December 2021 (PDF format)
English 6.6 MB
2022-04-15 10:30
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
English 1021.4 KB
2022-04-13 17:42
Comunicazione Internal Dealing
Italian 110.1 KB
2022-04-11 12:30
Relazione finanziaria annuale al 31.12.2021 formato PDF
Italian 8.7 MB
2022-04-08 13:05
AVVISO DI DEPOSITO DI ULTERIORE DOCUMENTAZIONE PER L’ASSEMBLEA DEGLI AZIONISTI…
Latin 276.4 KB
2022-04-08 12:39
RELAZIONE SULLA POLITICA IN MATERIA DI REMUNERAZIONE E SUI COMPENSI CORRISPOSTI
Italian 615.7 KB
2022-04-08 12:38
BOARD OF DIRECTORS EXPLANATORY REPORT ON THE AGENDA ITEMS
English 326.8 KB
2022-04-08 12:37
RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE SULLE MATERIE ALL’ORDIN…
Italian 333.7 KB
2022-04-08 12:32
ORDINARY SHAREHOLDERS' MEETING NOTICE OF CALL
English 251.6 KB

Automate Your Workflow. Get a real-time feed of all Fine Foods & Pharmaceuticals Ntm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fine Foods & Pharmaceuticals Ntm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fine Foods & Pharmaceuticals Ntm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.